Objects
Stewart, Scott G., Hill, Timothy A., Gilbert, Jayne, Ackland, Stephen P., Sakoff, Jennette A., McCluskey, Adam. Pergamon; 2007. Synthesis and biological evaluation of norcantharidin analogues: towards PP1 selectivity.
Garg, Madhu B., Ackland, Stephen P.. Springer; 2011. Pyridoxine to protect from oxaliplatin-induced neurotoxicity without compromising antitumour effect.
Garg, Madhu B., Sakoff, Jennette A., Ackland, Stephen P.. Elsevier; 2011. A simple HPLC method for plasma level monitoring of mitotane and its two main metabolites in adrenocortical cancer patients.
Tebbutt, Niall C., Wilson, Kate, Forgeson, Garry, Cunningham, David, Saunders, Mark P., Stockler, Martin R., Chua, Yujo, Zalcberg, John R., Simes, R. John, Price, Timothy J., Gebski, Val J., Cummins, Michelle M., Zannino, Dianna, van Hazel, Guy A., Robinson, Bridget, Broad, Adam, Ganju, Vinod, Ackland, Stephen P.. American Society of Clinical Oncology; 2010. Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: results of the Australasian Gastrointestinal Trials Group Randomized Phase III MAX Study.
Bryant, Jamie, Sanson-Fisher, Rob, Fradgley, Elizabeth, Regan, Timothy, Hobden, Breanne, Ackland, Stephen P.. BioMed Central; 2015. Oncology patients overwhelmingly support tissue banking.
Goldstein, David, Gainford, M Corona, Miller, Danielle, Shannon, Jenny, Brown, Chris, Tebbutt, Niall, Ackland, Stephen P., van Hazel, Guy, Jefford, Michael, Abdi, Ehtesham, Selva-Nayagam, Sid, Gebski, Val. Springer; 2011. Fixed-dose-rate gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas.
Hill, Timothy A., Stewart, Scott G., Ackland, Stephen P., Gilbert, Jayne, Sauer, Benjamin, Sakoff, Jennette A., McCluskey, Adam. Pergamon; 2007. Norcantharimides, synthesis and anticancer activity: synthesis of new norcantharidin analogues and their anticancer evaluation.
Hill, Timothy A., Stewart, Scott G., Sauer, Benjamin, Gilbert, Jayne, Ackland, Stephen P., Sakoff, Jennette A., McCluskey, Adam. Pergamon; 2007. Heterocyclic substituted cantharidin and norcantharidin analogues-synthesis, protein phosphatase (1 and 2A) inhibition, and anti-cancer activity.
Price, Timothy J., Segelov, Eva, Shapiro, Jeremy D., Burge, Matthew, Haller, Daniel G., Ackland, Stephen P., Tebbutt, Niall C., Karapetis, Christos S., Pavlakis, Nick, Sobrero, Alberto F., Cunningham, David. Expert Reviews; 2013. Current opinion on optimal treatment for colorectal cancer.
Ngan, Samuel Y., Burmeister, Bryan, McKendrick, Joseph, Leong, Trevor, Hartopeanu, Cris, Zalcberg, John, Mackay, John, Fisher, Richard J., Solomon, Michael, Goldstein, David, Joseph, David, Ackland, Stephen P., Schache, David, McClure, Bev, McLachlan, Sue-Anne. American Society of Clinical Oncology; 2012. Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group Trial 01.04.
Stockler, Martin R., Harvey, Vernon J., Gainford, M. Corona, Fong, Akiko, Paksec, Lisa, Sourjina, Tatiana, Zannino, Diana, Gebski, Val, Simes, R. John, Forbes, John F., Coates, Alan S., Francis, Prudence A., Byrne, Michael J., Ackland, Stephen P., Fitzharris, Bernie, Van Hazel , Guy, Wilcken, Nicholas R. C., Grimison, Peter S., Nowak, Anna K.. American Society of Clinical Oncology; 2011. Capecitabine versus classical cyclophosphamide, methotrexate, and fluorouracil as first-line chemotherapy for advanced breast cancer.
Wong, Mark, Balleine, Rosemary L., Hoskins, Janelle M., Mann, Graham J., Clarke, Christine L., Gurney, Howard, Blair, Elaine Y. L., McLachlan, Andrew J., Ackland, Stephen P., Garg, Madhu B., Evans, Scott, Farlow, David, Collins, Michael, Rivory, Laurent P.. American Society of Clinical Oncology; 2006. Predictors of vinorelbine pharmacokinetics and pharmacodynamics in patients with cancer.
Hill, Timothy A., Stewart, Scott G., Gordon, Christopher P., Ackland, Stephen P., Gilbert, Jayne, Sauer, Benjamin, Sakoff, Jennette A., McCluskey, Adam. Wiley; 2008. Norcantharidin analogues: synthesis, anticancer activity and protein phosphatase 1 and 2A inhibition.
McCluskey, Adam, Walkom, Cecilia, Bowyer, Michael C., Ackland, Stephen P., Gardiner, Emma, Sakoff, Jennette A.. Elsevier Science; 2001. Cantharimides: a new class of modified cantharidin analogues inhibiting protein phosphatases 1 and 2A.
McCluskey, Adam, Ackland, Stephen P., Bowyer, Michael C., Baldwin, Monique L., Garner, James, Walkom, Cecilia C., Sakoff, Jennette A.. Academic Press; 2003. Cantharidin analogues: synthesis and evaluation of growth inhibition in a panel of selected tumour cell lines.
Sakoff, Jennette A., Howitt, Ian J., Ackland, Stephen P., McCluskey, Adam. Springer-Verlag; 2004. Serine/threonine protein phosphatase inhibition enhances the effect of thymidylate synthase inhibition.
Fradgley, Elizabeth A., Paul, Christine L., Bryant, Jamie, Collins, Nicolas, Ackland, Stephen P., Bellamy, Douglas, Levi, Christopher R.. Sage; 2016. Collaborative patient-centered quality improvement: a cross-sectional survey comparing the types and numbers of quality initiatives selected by patients and health professionals.
McLachlan, Sue-Anne, Fisher, Richard J., MacKay, John, Ngan, Samuel Y., Zalcberg, John, Solomon, Michael, Burmeister, Bryan, Goldstein, David, Leong, Trevor, Ackland, Stephen P., McKendrick, Joseph, McClure, Bev. Elsevier; 2016. The impact on health-related quality of life in the first 12 months: a randomised comparison of preoperative short-course radiation versus long-course chemoradiation for T3 rectal cancer (Trans-Tasman Radiation Oncology Group Trial 01.04).
Ackland, Stephen P., Bull, James M., Boyle, Frances M.. Wiley-Blackwell Publishing; 2009. Nab-paclitaxel: a bright new SPARC in taxane therapy of cancer (editorial).